Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 28,750

Document Document Title
WO/2015/041601A1
The present invention relates to a method for synthesizing an optionally substituted furoic acid by dehydrating a biomass and oxidizing the optionally substituted furan derived from the dehydration reaction. Water extraction has been inc...  
WO/2015/041492A1
This invention relates to a compound for an organic electroluminescent device and to an organic electroluminescent device including the same. According to the present invention, the organic electroluminescent device including the compoun...  
WO/2015/042407A1
The present disclosure provides methods to produce 5-(halomethyl)furfural, including 5- (chloromethyl)furfural, by acid-catalyzed conversion of C6 saccharides, including isomers thereof, polymers thereof, and certain derivatives thereof....  
WO/2015/038463A1
Polymeric compositions are provided that include a furan 2,5-di-ester or tetrahydrofuran 2,5-di-ester plasticizer. The plasticizer has low odor, has good compatibility with a variety of polymers such as hydrophilic polymeric materials, a...  
WO/2015/036402A1
The invention relates to novel compounds of formula (I), where R = -H, -methyl, ethyl, O-methyl or O-ethyl, R1= -H, -methyl, ethyl, O-methyl or O-ethyl and n = 1 or 2. The invention also relates to the uses of said compounds as fragrance...  
WO/2015/036910A1
Disclosed are oxime ester compounds which have specific benzo (unsaturated 5-membered ring)-carbonyl group and their use as photoinitiators in photopolymerizable compositions, in particular in photoresist formulations for display applica...  
WO/2015/038548A1
The disclosed process relates to an improved process for manufacturing THF from a reaction mixture comprising BDO in the presence of an acid catalyst in a reaction vessel comprising a distillation reaction zone, wherein the acid catalyst...  
WO/2015/033559A1
Provided is an anthracene derivative represented by formula (1). In formula (1), one of R11 to R20 is used to bond to L1, and those of R11 to R20 not used to bond to L1 are each independently a hydrogen atom, a halogen atom, a cyano grou...  
WO/2015/034964A1
The present disclosure relates to methods of producing hemicellulose and conversion products thereof from a biomass. Also provided are hemicellulose products and other conversion products thereof.  
WO/2015/032328A1
The present invention relates to an indane derivative, a preparation method therefor, and a pharmaceutical application thereof. Specifically, the present invention relates to a compound shown in formula (I), or a stereoisomer thereof, an...  
WO/2015/032794A1
The present invention relates to tetrahydrofuran derivatives, a plasticizer composition containing said tetrahydrofuran derivatives, molding materials containing a thermoplastic polymer and such a tetrahydrofuran derivative, to a process...  
WO/2015/031753A1
The invention provides a method for preparing a 2,5-dialkyl furan. The method includes forming a reaction mixture containing a catalyst, a hydrogen source, and 2-haloalkylfuran starting material under conditions sufficient to form the 2,...  
WO/2015/031352A1
The present disclosure relates to processes for preparing dronedarone or pharmaceutically acceptable salts thereof.  
WO/2015/030189A1
Provided is a compound which exhibits bone formation acceleration activity (and/or bone resorption suppression activity). The compound is either a compound having a general formula (I) (wherein the substituents are as defined in the desc...  
WO/2015/029062A1
Disclosed herein an efficient process for synthesis of benzofuran analogues having anti-inflammatory activity which comprises, Ru-catalyzed branched and linear selective alkylation of aroylbenzofurans formula-I with alpha, beta unsaturat...  
WO/2015/030590A1
An acid composition comprising 2-formyl-furan-5-carboxylic acid and 2,5-furandicarboxylic acid is purified in a process which comprises; contacting the acid composition with an alcohol to obtain an esterified composition; and separating ...  
WO/2015/030505A1
Provided is a method for preparing 5-hydroxymethyl-2-furfural using an acid catalyst in a condition with the presence of an ethylene glycol-based compound. The method for preparing the 5-hydroxymethyl-2-furfural involves using a linear o...  
WO/2015/027702A1
The present invention relates to compounds represented by general formulas I, IIa, IIb, III and IV and preparation method therefor. Ar1 represents substituted o-arylene or substituted o-heteroarylene; Ar2 represents bis(o-arylene) or bis...  
WO/2015/024403A1
The invention relates to an N-heterocyclic carbene-type palladium catalyst and a preparation method and use thereof. In the preparation method, glyoxal is used as a raw material and together with a Lewis acid or Bronsted acid to synthesi...  
WO/2015/025859A1
A radiation-sensitive resin composition that comprises a polymer having an acid-dissociable group-containing structural unit, a compound comprising a radiolytic onium cation and a counter anion, and a solvent, wherein the counter anion h...  
WO/2015/026234A1
The invention relates to a method for preparing a chemical compound, comprising subjecting a levulinic acid source, preferably a compound selected from the group of levulinic acid, levulinic acid anhydrides, levulinic acid salts, levulin...  
WO/2015/023918A2
Provided herein are methods of producing dialkylfurans, such as 2,5-dimethylfuran, and other alkyl furans, such as 2-methylfuran. For example, 2,5-dimethylfuran may be produced by reducing (5-methylfuran-2-yl)methanol or 2-(chloromethyl)...  
WO/2015/022265A3
Compounds of the formula in which the substituents are as defined in claim 1, are suitable for use as nematicides.  
WO/2015/020845A1
A process is described for producing furan from furfural from biomass, wherein furfural in an aqueous mass or stream from the liquefaction of biomass or a biomass fraction including one or more furfural precursors is extracted into an or...  
WO/2015/014230A1
The present invention relates to a matrix metalloproteinase inhibitor and a use thereof. In particular, the matrix metalloproteinase inhibitor has a structure as shown in formula (I) or a pharmaceutically acceptable salt thereof, and can...  
WO/2015/010655A1
Triadic fused cyclic carboxylic acids derivatives, preparation method therefor and pharmaceutical use thereof, particularly relating to compounds represented by general formula (I), stereoisomers, hydrates, solvates, metabolites, eutecti...  
WO/2015/011614A1
An organic compound represented by General Formula (G1) that emits blue light with high color purity and has a long lifetime is provided as a novel substance. The organic compound is a fluorescent organic compound having a structure in w...  
WO/2015/013456A1
Provided herein are pH indicator compounds that optionally include one or more indicator compounds of Formulas (I)-(IV). Also provided are implantable medical devices to which the reaction product of the indicator compounds of Formula (I...  
WO/2015/007601A1
The invention relates to continuous process for the production of a valuable compound from a lignocellulosic biomass, said process comprising: subjecting a slurried lignocellulosic biomass to an acid hydrolysis reaction in a reactor havi...  
WO/2015/006893A1
The present invention relates to uses of a sesquiterpene lactone compound and a derivative thereof in preparation of drugs, relates to the technical field of drugs, specially relates to uses of a formula (I) compound in preparation of dr...  
WO/2015/009076A1
The present invention relates to a specific combination of a dopant compound comprising an amino-pyrene and a host compound comprising a di-aryl subsituted anthracene, and an organic electroluminescent device comprising the same. The org...  
WO/2015/004273A1
The present invention relates to a method for the effective conversion of one or more mono-, di-, oligo- or polysaccharides to hydroxymethylfurfural (HMF), in an ionic liquid by means of a chromium catalyst mixture comprising chromium (I...  
WO/2015/006715A1
The present invention provides dehydroleucodine derivatives. In particular, the present invention provides amine derivatives of dehydroleucodine and methods of using dehydroleucodine and the amine derivatives of dehydroleucodine to inhib...  
WO/2015/002230A1
The present invention relates to compounds (I), which have RORĪ³t inhibitory effects, and salts thereof. In formula (I), each notation is as described in the Specification. (I)  
WO/2015/001422A3
Embodiments of the present disclosure provide for an aromatic dianhydride, a method of making an aromatic dianhydride, an aromatic dianhydride-based polyimide, a method of making an aromatic dianhydride-based polyimide, and the like,  
WO/2015/000070A1
Disclosed is a compound of formula 1, or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, R6, R7, R7', R8, R9, R10, R11, R12 and R13 are as disclosed herein. Also, disclosed is a process for the preparation of the co...  
WO/2015/003166A1
The invention generally relates to substituted benzofuranyl and substituted benzoxazolyl compounds, and more particularly to a compound represented by Structural Formula (A) : or a pharmaceutically acceptable salt thereof, wherein the va...  
WO/2015/002208A1
A compound characterized by being represented by general formula (1). In general formula (1), n is 1 or 2. Ar1 is represented by general formula (2). Ar2 is a substituted or un-substituted aromatic hydrocarbon group having 6-30 carbons, ...  
WO/2015/000412A1
The present invention relates to a benzocyclobutene derivative and a preparation method and pharmaceutical application thereof. Specifically, the present invention relates to a compound expressed by formula (I) or a stereoisomer, hydrate...  
WO/2014/205592A1
Compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV in...  
WO/2014/207764A1
An efficient, hydrogen gas-free, high yielding, moderate temperature and safe-to-handle process for producing furan and its derivatives from furfural, which comprises contacting furfural and water-isopropanol mixture with a supported Pd ...  
WO/2014/207604A3
Disclosed is a process for preparing carboxylic acids and/or carboxylic anhydrides by gas phase oxidation of aromatic hydrocarbon, in which a gas stream comprising at least one aromatic hydrocarbon and molecular oxygen is passed continuo...  
WO/2014/205593A1
Disclosed are compounds of formula (I) that are useful as hepatitis C virus (HCV) NSSB polymerise inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NSSB polymerise activity, for treating or pre...  
WO/2014/208132A1
Provided are: a compound that contains a phenolic hydroxyl group and that has superior thermal resistance and flame resistance of the cured product thereof; a phenolic resin containing the compound that contains a phenolic hydroxyl group...  
WO/2014/209112A1
The invention is directed to a process for the preparation of 2,5- furandicarboxylic acid (FDCA) by fermentation comprising fermenting a suitable starting compound to produce an aqueous solution of a salt of FDCA having a pH of at least ...  
WO/2014/207603A3
Disclosed is a process for preparing phthalic anhydride by gas phase oxidation of aromatic hydrocarbons, in which a gas stream comprising at least one aromatic hydrocarbon and molecular oxygen is passed continuously over a thermostatted ...  
WO/2014/203541A1
The purpose of the present invention is to provide an organic EL element which has a long service life, while achieving a lower driving voltage. An aromatic amine derivative according to the present invention is represented by formula (1...  
WO/2014/204175A1
The present invention relates to a crystalline form of (2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)benzofuran) and a method for preparing the same. The crystalline form of (2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)benzofuran) according...  
WO/2014/203058A1
The present invention relates to a process for preparing Dronedarone or its pharmaceutically acceptable salts thereof, by reacting 5-amino-3-[4-(3-di-n-butyl aminopropoxy)benzoyl]-2-n-butyl benzofuran or a salt thereof with methanesulfon...  
WO/2014/199306A3
A process is described for the preparation of 5-hydroxymethylfurfural (HMF), which comprises the following steps: provision or preparation of a starting mixture, comprising one, two or more starting compounds selected from the group cons...  

Matches 51 - 100 out of 28,750